| Stage | CL | % of rev | KVUE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $3.9B | 100.00% | CL ×1.38 |
| Gross profit | $3.2B | 60.22% | $2.3B | 59.55% | CL +0.7pp |
| Operating income | $1.1B | 20.26% | $706M | 18.17% | CL +2.1pp |
| Pre-tax income | $1.0B | 18.98% | $609M | 15.67% | CL +3.3pp |
| Net income | $779M | 14.51% | $430M | 11.07% | CL +3.4pp |
| Stage | CL | KVUE | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $3.9B100.00% | CL ×1.38 |
| Gross profit | 60.22%$3.2B | 59.55%$2.3B | CL +0.7pp |
| Operating income | 20.26%$1.1B | 18.17%$706M | CL +2.1pp |
| Pre-tax income | 18.98%$1.0B | 15.67%$609M | CL +3.3pp |
| Net income |
| 14.51%$779M |
| 11.07%$430M |
| CL +3.4pp |